N-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone

C103H106N20O7 — CID 157336878

IUPACN-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone
SMILESCC(=O)N1CCCN(C(=O)c2ccc(Nc3nccc(-c4ccc(C)cc4)n3)cc2)CC1.Cc1ccc(-c2ccnc(Nc3ccc(C(=O)N4CCN(C(=O)c5ccco5)CC4)cc3)n2)cc1.Cc1ccc(-c2ccnc(Nc3ccc(C(=O)N4CCN(c5ccccc5)CC4)cc3)n2)cc1.Cc1ccc(-c2ccnc(Nc3ccc(C(=O)NCCCN(C)C)cc3)n2)cc1
InChIInChI=1S/C28H27N5O.C27H25N5O3.C25H27N5O2.C23H27N5O/c1-21-7-9-22(10-8-21)26-15-16-29-28(31-26)30-24-13-11-23(12-14-24)27(34)33-19-17-32(18-20-33)25-5-3-2-4-6-25;1-19-4-6-20(7-5-19)23-12-13-28-27(30-23)29-22-10-8-21(9-11-22)25(33)31-14-16-32(17-15-31)26(34)24-3-2-18-35-24;1-18-4-6-20(7-5-18)23-12-13-26-25(28-23)27-22-10-8-21(9-11-22)24(32)30-15-3-14-29(16-17-30)19(2)31;1-17-5-7-18(8-6-17)21-13-15-25-23(27-21)26-20-11-9-19(10-12-20)22(29)24-14-4-16-28(2)3/h2-16H,17-20H2,1H3,(H,29,30,31);2-13,18H,14-17H2,1H3,(H,28,29,30);4-13H,3,14-17H2,1-2H3,(H,26,27,28);5-13,15H,4,14,16H2,1-3H3,(H,24,29)(H,25,26,27)
InChIKeyBFXYUBGOEVKQFO-UHFFFAOYSA-N
MW1736.11 g/mol
LogP17.31
Rot. Bonds22

About N-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone

N-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone (PubChem CID 157336878) has the molecular formula C103H106N20O7 and a molecular weight of 1736.11 g/mol. Its IUPAC name is N-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone.

Molecular Properties

Compound NameN-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone
PubChem CID157336878
Molecular FormulaC103H106N20O7
Molecular Weight1736.11 g/mol
Exact Mass1734.86
IUPAC NameN-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone
SMILESCC(=O)N1CCCN(C(=O)c2ccc(Nc3nccc(-c4ccc(C)cc4)n3)cc2)CC1.Cc1ccc(-c2ccnc(Nc3ccc(C(=O)N4CCN(C(=O)c5ccco5)CC4)cc3)n2)cc1.Cc1ccc(-c2ccnc(Nc3ccc(C(=O)N4CCN(c5ccccc5)CC4)cc3)n2)cc1.Cc1ccc(-c2ccnc(Nc3ccc(C(=O)NCCCN(C)C)cc3)n2)cc1
InChIInChI=1S/C28H27N5O.C27H25N5O3.C25H27N5O2.C23H27N5O/c1-21-7-9-22(10-8-21)26-15-16-29-28(31-26)30-24-13-11-23(12-14-24)27(34)33-19-17-32(18-20-33)25-5-3-2-4-6-25;1-19-4-6-20(7-5-19)23-12-13-28-27(30-23)29-22-10-8-21(9-11-22)25(33)31-14-16-32(17-15-31)26(34)24-3-2-18-35-24;1-18-4-6-20(7-5-18)23-12-13-26-25(28-23)27-22-10-8-21(9-11-22)24(32)30-15-3-14-29(16-17-30)19(2)31;1-17-5-7-18(8-6-17)21-13-15-25-23(27-21)26-20-11-9-19(10-12-20)22(29)24-14-4-16-28(2)3/h2-16H,17-20H2,1H3,(H,29,30,31);2-13,18H,14-17H2,1H3,(H,28,29,30);4-13H,3,14-17H2,1-2H3,(H,26,27,28);5-13,15H,4,14,16H2,1-3H3,(H,24,29)(H,25,26,27)
InChIKeyBFXYUBGOEVKQFO-UHFFFAOYSA-N
XLogP17.31
TPSA301.51 Ų
H-Bond Donors5
H-Bond Acceptors21
Rotatable Bonds22
Heavy Atoms130
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001736.11
LogP ≤ 517.31
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone?
The IUPAC name of N-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone (CID 157336878) is N-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone.
What is the SMILES notation for N-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone?
The canonical SMILES for N-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone is CC(=O)N1CCCN(C(=O)c2ccc(Nc3nccc(-c4ccc(C)cc4)n3)cc2)CC1.Cc1ccc(-c2ccnc(Nc3ccc(C(=O)N4CCN(C(=O)c5ccco5)CC4)cc3)n2)cc1.Cc1ccc(-c2ccnc(Nc3ccc(C(=O)N4CCN(c5ccccc5)CC4)cc3)n2)cc1.Cc1ccc(-c2ccnc(Nc3ccc(C(=O)NCCCN(C)C)cc3)n2)cc1.
What is the InChIKey of N-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone?
The InChIKey is BFXYUBGOEVKQFO-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H27N5O.C27H25N5O3.C25H27N5O2.C23H27N5O/c1-21-7-9-22(10-8-21)26-15-16-29-28(31-26)30-24-13-11-23(12-14-24)27(34)33-19-17-32(18-20-33)25-5-3-2-4-6-25;1-19-4-6-20(7-5-19)23-12-13-28-27(30-23)29-22-10-8-21(9-11-22)25(33)31-14-16-32(17-15-31)26(34)24-3-2-18-35-24;1-18-4-6-20(7-5-18)23-12-13-26-25(28-23)27-22-10-8-21(9-11-22)24(32)30-15-3-14-29(16-17-30)19(2)31;1-17-5-7-18(8-6-17)21-13-15-25-23(27-21)26-20-11-9-19(10-12-20)22(29)24-14-4-16-28(2)3/h2-16H,17-20H2,1H3,(H,29,30,31);2-13,18H,14-17H2,1H3,(H,28,29,30);4-13H,3,14-17H2,1-2H3,(H,26,27,28);5-13,15H,4,14,16H2,1-3H3,(H,24,29)(H,25,26,27).
What are the key properties of N-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone?
N-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone has a molecular weight of 1736.11 g/mol, XLogP of 17.31, 22 rotatable bonds, 5 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(dimethylamino)propyl]-4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzamide;[4-(furan-2-carbonyl)piperazin-1-yl]-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]methanone;1-[4-[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]benzoyl]-1,4-diazepan-1-yl]ethanone;[4-[[4-(4-methylphenyl)pyrimidin-2-yl]amino]phenyl]-(4-phenylpiperazin-1-yl)methanone is sourced from PubChem (CID 157336878), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).